Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00665990
Title Phase I Study of Bevacizumab and Sorafenib Combined With Low Dose Cyclophosphamide in Patients With Refractory Solid Tumors and Leukemia
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors St. Jude Children's Research Hospital
Indications

Advanced Solid Tumor

childhood leukemia

Therapies

Bevacizumab + Cyclophosphamide + Sorafenib

Age Groups: child
Covered Countries USA


No variant requirements are available.